Service for determining drug addiction status at public medical facilities in Vietnam from January 8, 2025

Tan Dai

09:30, 25/11/2024

The following article contains information regarding the service for determining drug addiction status at public healthcare facilities in Vietnam from January 8, 2025, as stipulated in Circular 40/2024/TT-BYT.

Nhóm dịch vụ xác định tình trạng nghiện ma túy tại cơ sở y tế công lập từ 08/1/2025

Service for determining drug addiction status at public medical facilities in Vietnam from January 8, 2025 (Image from the Internet)

On November 22, 2024, the Minister of Health of Vietnam issued Circular 40/2024/TT-BYT on the economic-technical characteristics of preventive medical services in the field of HIV/AIDS prevention and control at public health facilities.

Service for determining drug addiction status at public medical facilities in Vietnam from January 8, 2025

The group of clinical diagnostic and treatment services for HIV/AIDS and determining drug addiction status in Vietnam includes 62 services as prescribed in Appendix III issued together with Circular 40/2024/TT-BYT including:

No	Detailed Name	Specific Type/Basic Features
1	Rapid HIV Ab test	Diagnostic tests for HIV and tests for monitoring HIV treatment include: - HIV screening; - Confirming HIV; - Measuring HIV load; - Early diagnosis of HIV infection; - Gene sequencing; - CD4 cell count.
2	Rapid HIV Ag/Ab test
3	Semi-automatic HIV Ag/Ab immunological test
4	Automatic HIV Ag/Ab immunological test
5	Semi-automatic HIV Ab immunological test
6	Automatic HIV Ab immunological test
7	HIV particle agglutination
8	HIV Ab Western blot
9	Confirming HIV
10	Automatic HIV load measurement system
11	HIV load measurement Realtime PCR
12	HIV load measurement - HIV Xpert
13	HIV DNA PCR
14	HIV DNA Realtime PCR
15	HIV Realtime PCR on dried blood spot samples
16	HIV genotype gene sequencing (HIV gene sequencing using Sanger method for a gene)
17	HIV gene sequencing using NGS method for a gene
18	HIV drug resistance gene sequencing
19	CD4 quantification, or CD4 cell count
20	HBsAg (HBsAg using chemiluminescent technique or rapid HBsAg test, or semi-automatic HBsAg immunological test, or automatic HBsAg immunological test)	Hepatitis B test in HIV treatment diagnosis
21	Anti-HCV (Anti-HCV using chemiluminescent technique, or rapid HCV Ab test, or semi-automatic HCV Ab immunological test, or automatic HCV Ab immunological test, or semi-automatic HCV Ag/Ab immunological test, or automatic HCV Ag/Ab immunological test)	Hepatitis C test in HIV treatment diagnosis
22	Syphilis (rapid Treponema pallidum test, or qualitative and quantitative Treponema pallidum TPHA, and Treponema pallidum RPR qualitative and quantitative, or Treponema pallidum PCR, or Real-time Treponema pallidum PCR)	Syphilis test in HIV treatment diagnosis
23	Gonorrhea (Neisseria gonorrhoeae staining, or Neisseria gonorrhoeae culture, identification and drug resistance, or Neisseria gonorrhoeae PCR, or Real-time Neisseria gonorrhoeae PCR, or automatic system Real-time Neisseria gonorrhoeae PCR)	Gonorrhea test in HIV treatment diagnosis
24	Chlamydia (rapid Chlamydia test, or semi-automatic Chlamydia Ab immunological test, or automatic Chlamydia Ab immunological test, or Chlamydia PCR, or Real-time Chlamydia PCR, or automatic system Real-time Chlamydia PCR)	Chlamydia test in HIV treatment diagnosis
25	Complete peripheral blood cell analysis (using manual method, or impedance count machine, or laser count machine, or fully automated system).	Blood formula test
26	ALT (GPT) activity measurement	Blood biochemical test
27	AST (GOT) activity measurement
28	Blood Creatinine quantification
29	Blood Urea quantification
30	Glucose quantification
31	Electrolytes (Na, K, Cl) [Blood]
32	Total blood Cholesterol quantification.
33	HDL-C (High density lipoprotein Cholesterol) [Blood] quantification
34	LDL-C (Low density lipoprotein Cholesterol) [Blood] quantification
35	Triglyceride [Blood] quantification
36	Qualitative drug test for one indicator in urine	Clinical substance use test
37	Screening and qualitative test for 5 types of drugs
38	Rapid test for opiate substance detection in urine, or Qualitative Opiate (rapid test) [urine]
39	Rapid test for illicit drug detection in urine
40	Qualitative Amphetamine (rapid test) [urine]
41	Qualitative Marijuana (THC) (rapid test) [urine]
42	Qualitative Morphine (rapid test) [urine]
43	Qualitative Codeine (rapid test) [urine]
44	Qualitative Heroin (rapid test) [urine]
45	Methamphetamine (rapid test)
46	Urinary Cocaine (rapid test)
47	Chest X-ray straight view	Imaging and functional clinical
48	Routine ECG
49	Abdominal ultrasound (liver, gallbladder, pancreas, spleen, kidneys, bladder)
50	Cranial CT scan
51	EEG measurement (computerized or video)
52	Cerebral flow measurement
53	Psychological test	Clinical psychological testing
54	Collection, preservation, and transport of blood specimens (blood, serum, plasma...) for serological testing	Collection, preservation, and transport of specimens
55	Collection, preservation, and transport of dried blood spot samples
56	Collection, preservation, and transport of blood specimens (blood, serum, plasma...) for molecular biological testing
57	Production and supply of HIV serological internal control kits	Providing internal control samples on serum samples to assess test quality through the production and distribution of kit samples for testing units to perform to ensure test quality when providing services
58	Production and supply of CD4 cell count internal control kits
59	Production and supply of HIV-HBsAg-HCV-Syphilis serological internal control kits
60	Production and supply of external assessment programs, kit samples evaluating the capacity of HIV serological testing laboratories	Providing external control serological kits on serum samples to assess test quality serving the work of HIV/AIDS prevention through the production, distribution of kit samples and analysis, and evaluation of participating units' results.
61	Production and supply of CD4 cell count external quality assessment programs
62	Production and supply of HIV-HBsAg-HCV-Syphilis serological external quality assessment programs

Refer to the Circular 40/2024/TT-BYT which takes effect from January 8, 2025.

>> CLICK HERE TO READ THIS ARTICLE IN VIETNAMESE

0 lượt xem

- This translation is generated by OpenAI's GPT-4o model;
- The legal regulations in this article are according to Vietnamese Law;
- This English translation is for reference purposes only and not a definitive translation of the original Vietnamese texts;
- Articles may be compiled from a variety of sources;
- Applicable Terms may have expired at the time you are reading;
- If you have any questions about the copyright of the article, please contact us via email banquyen@lawnet.vn

Address:	19 Nguyen Gia Thieu, Vo Thi Sau Ward, District 3, Ho Chi Minh City
Phone:	(028) 7302 2286
E-mail:	info@lawnet.vn